Dennison, J.L.; Al-Ali, H.; Volmar, C.-H.; Brothers, S.; Watts, J.; Wahlestedt, C.; Lohse, I.
Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. Cancers 2022, 14, 4094.
https://doi.org/10.3390/cancers14174094
AMA Style
Dennison JL, Al-Ali H, Volmar C-H, Brothers S, Watts J, Wahlestedt C, Lohse I.
Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. Cancers. 2022; 14(17):4094.
https://doi.org/10.3390/cancers14174094
Chicago/Turabian Style
Dennison, Jessica L., Hassan Al-Ali, Claude-Henry Volmar, Shaun Brothers, Justin Watts, Claes Wahlestedt, and Ines Lohse.
2022. "Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients" Cancers 14, no. 17: 4094.
https://doi.org/10.3390/cancers14174094
APA Style
Dennison, J. L., Al-Ali, H., Volmar, C.-H., Brothers, S., Watts, J., Wahlestedt, C., & Lohse, I.
(2022). Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. Cancers, 14(17), 4094.
https://doi.org/10.3390/cancers14174094